Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BJDX NASDAQ:CODX NASDAQ:LFWD NASDAQ:NURO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.57-2.5%$1.71$1.46▼$37.50$2.41M0.47662,816 shs24,183 shsCODXCo-Diagnostics$0.28+1.5%$0.28$0.23▼$2.23$9.25M0.6319,907 shs652,147 shsLFWDLifeward$0.73-1.8%$1.02$0.50▼$4.77$8.19M0.02836,021 shs175,493 shsNURONeuroMetrix$4.55+4.4%$4.55$2.66▼$4.73$9.37M1.8216,958 shs35,522 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics0.00%-2.42%-1.23%-18.69%-94.25%CODXCo-Diagnostics+6.79%+11.16%+3.44%-19.40%-78.29%LFWDLifeward+0.49%-0.92%-32.40%-47.63%-81.27%NURONeuroMetrix0.00%0.00%0.00%+3.32%+23.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBJDXBluejay Diagnostics0.9374 of 5 stars0.05.00.00.02.20.00.6CODXCo-Diagnostics4.1172 of 5 stars3.53.00.04.41.90.01.3LFWDLifeward2.7239 of 5 stars3.52.00.00.03.80.01.3NURONeuroMetrixN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBJDXBluejay Diagnostics 0.00N/AN/AN/ACODXCo-Diagnostics 3.00Buy$5.501,867.80% UpsideLFWDLifeward 3.00Buy$9.001,132.71% UpsideNURONeuroMetrix 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BJDX, NURO, CODX, and LFWD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBJDXBluejay Diagnostics$250K9.36N/AN/A$10.34 per share0.15CODXCo-Diagnostics$3.91M2.40N/AN/A$1.70 per share0.16LFWDLifeward$25.66M0.31N/AN/A$2.14 per share0.34NURONeuroMetrix$3.03M3.09N/AN/A$13.18 per share0.35Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBJDXBluejay Diagnostics-$7.72M-$379.74N/A∞N/AN/A-322.46%-262.96%8/13/2025 (Estimated)CODXCo-Diagnostics-$37.64M-$1.17N/AN/AN/A-1,025.45%-60.16%-52.69%8/6/2025 (Estimated)LFWDLifeward-$28.94M-$3.04N/AN/AN/A-108.21%-101.96%-70.49%8/13/2025 (Estimated)NURONeuroMetrix-$6.53M-$4.59N/A∞N/A-203.71%-42.56%-39.26%8/4/2025 (Estimated)Latest BJDX, NURO, CODX, and LFWD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CODXCo-Diagnostics-$0.25N/AN/AN/AN/AN/A8/13/2025Q2 2025LFWDLifeward-$0.25N/AN/AN/A$6.62 millionN/A5/15/2025Q1 2025LFWDLifeward-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million5/13/2025Q1 2025BJDXBluejay DiagnosticsN/A-$3.37N/A-$3.37N/AN/A5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBJDXBluejay DiagnosticsN/AN/AN/AN/AN/ACODXCo-DiagnosticsN/AN/AN/AN/AN/ALFWDLifewardN/AN/AN/AN/AN/ANURONeuroMetrixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBJDXBluejay DiagnosticsN/A2.712.71CODXCo-DiagnosticsN/A4.434.23LFWDLifewardN/A2.181.43NURONeuroMetrixN/A13.8812.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBJDXBluejay Diagnostics18.47%CODXCo-Diagnostics14.99%LFWDLifeward26.76%NURONeuroMetrix19.40%Insider OwnershipCompanyInsider OwnershipBJDXBluejay Diagnostics0.08%CODXCo-Diagnostics8.40%LFWDLifeward2.70%NURONeuroMetrix7.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBJDXBluejay Diagnostics91.49 million1.49 millionNot OptionableCODXCo-Diagnostics10033.57 million30.75 millionOptionableLFWDLifeward6011.01 million10.71 millionOptionableNURONeuroMetrix202.06 million1.90 millionNot OptionableBJDX, NURO, CODX, and LFWD HeadlinesRecent News About These CompaniesNeuroMetrix (NASDAQ:NURO) Stock Price Passes Above 200-Day Moving Average - Here's WhyJuly 9, 2025 | americanbankingnews.comelectroCore completes acquisition of neurotechnology solution provider NeuroMetrixMay 5, 2025 | msn.comelectroCore Acquires NeuroMetrix, Expands Pain Management PortfolioMay 3, 2025 | investing.comNeuroMetrix finalizes acquisition by electroCoreMay 3, 2025 | investing.comNuro hits communication milestone with non-surgical neurotechMay 2, 2025 | massdevice.comNeuroMetrix shareholders approve merger with electroCoreMarch 27, 2025 | investing.comNEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NUROJanuary 6, 2025 | businesswire.comHere’s Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10January 6, 2025 | insidermonkey.comNeurometrix Announces Board Changes for 2024December 30, 2024 | markets.businessinsider.comNeuroMetrix announces Bradley Fluegel to resign from BoardDecember 30, 2024 | markets.businessinsider.com$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – PWOD, CARA, NURO, VOXXDecember 20, 2024 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of ShareholdersDecember 18, 2024 | stockhouse.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating NeuroMetrix, Inc. BuyoutDecember 18, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of NeuroMetrix, Inc. - NURODecember 18, 2024 | prnewswire.comElectroCore to Buy NeuroMetrix, Adding Quell PlatformDecember 18, 2024 | marketwatch.comNURO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeuroMetrix, Inc. Is Fair to ShareholdersDecember 17, 2024 | businesswire.comNeuroMetrix Merges with electroCore, Expands Quell AccessDecember 17, 2024 | tipranks.comElectrocore to Acquire NeuroMetrix Enhancing Bioelectronic OfferingsDecember 17, 2024 | tipranks.comNeuroMetrix, Inc. to Be Acquired by electroCore, Inc. in Strategic Merger AgreementDecember 17, 2024 | quiverquant.comQelectroCore, Inc. Announces Acquisition of NeuroMetrix, Inc. to Enhance Bioelectronic Health and Wellness Offerings with Quell® PlatformDecember 17, 2024 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBJDX, NURO, CODX, and LFWD Company DescriptionsBluejay Diagnostics NASDAQ:BJDX$1.57 -0.04 (-2.48%) Closing price 04:00 PM EasternExtended Trading$1.58 +0.00 (+0.32%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Co-Diagnostics NASDAQ:CODX$0.28 +0.00 (+1.45%) Closing price 04:00 PM EasternExtended Trading$0.28 +0.00 (+0.18%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Lifeward NASDAQ:LFWD$0.73 -0.01 (-1.82%) Closing price 04:00 PM EasternExtended Trading$0.73 0.00 (-0.01%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.NeuroMetrix NASDAQ:NURONeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
